0001299933-12-002217.txt : 20120928 0001299933-12-002217.hdr.sgml : 20120928 20120928161305 ACCESSION NUMBER: 0001299933-12-002217 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120924 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20120928 DATE AS OF CHANGE: 20120928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORNERSTONE THERAPEUTICS INC CENTRAL INDEX KEY: 0001145404 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043523569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50767 FILM NUMBER: 121116861 BUSINESS ADDRESS: STREET 1: 1255 CRESCENT GREEN DRIVE STREET 2: SUITE 250 CITY: CARY STATE: NC ZIP: 27518 BUSINESS PHONE: 919-678-6611 MAIL ADDRESS: STREET 1: 1255 CRESCENT GREEN DRIVE STREET 2: SUITE 250 CITY: CARY STATE: NC ZIP: 27518 FORMER COMPANY: FORMER CONFORMED NAME: CRITICAL THERAPEUTICS INC DATE OF NAME CHANGE: 20010719 8-K 1 htm_46103.htm LIVE FILING Cornerstone Therapeutics Inc. (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   September 24, 2012

Cornerstone Therapeutics Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 000-50767 04-3523569
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
1255 Crescent Green Drive, Suite 250, Cary, North Carolina   27518
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   919-678-6611

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 24, 2012, Cornerstone Therapeutics Inc. (the "Company") notified Vincent T. Morgus, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, that the Company had determined to exercise its rights under its employment agreement with Mr. Morgus to terminate Mr. Morgus’s employment. Accordingly, immediately following such notification, Mr. Morgus ceased serving as the Company’s Executive Vice President, Chief Financial Officer and Treasurer. However, Mr. Morgus will remain an employee of the Company through October 19, 2012. Mr. Morgus's termination is not due to any disagreements with the Company on any matter relating to the Company's operations, policies, practices or otherwise. The Company will immediately begin seeking a replacement for Mr. Morgus.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Cornerstone Therapeutics Inc.
          
September 28, 2012   By:   /s/Andrew K. W. Powell
       
        Name: Andrew K. W. Powell
        Title: Executive Vice President, General Counsel and Secretary